Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

About Us

BOL was one of the first licensed medical cannabis cultivators in Israel and have been at the forefront of the Israeli medical cannabis industry since 2008. We are a vertically integrated company in the medical cannabis and cannabinoid based pharmaceutical industries with operations spanning every stage of the value chain from cultivation through production and extraction, formulation and product development, and product research and testing.

Production

We are a trusted IMC-GMP certified supplier of APIs to leading pharmaceutical companies, universities and research partnerships.

icon_pharmaceutical

Pharmaceutical Development

Comprehensive cannabinoid clinical trial portfolio comprising 34 Phase IIa trials

Become
a global leader in producing medical cannabis and innovative
cannabis products, including new
pharmaceutical drugs.

pharmacies in Israel currently supplied

Square feet of fully operational greenhouses

Square feet state of the art IMC GMP certified manufacturing facility in Revadim , Israel

BOL ADVANTAGES

$

Low-cost structure production capabilities due to favorable climate conditions, regulation, low energy footprint and labor cost.

$

Producing a range of 99% pure cannabinoids: THC, CBD as well as CBN, CBG and CBC to supply commercial, clinical, and research entities.

$

Pipeline of cannabinoid based
pharmaceutical products under development across a range of
Indications; comprehensive 
cannabinoid clinical trial portfolio comprising 34 Phase IIa trials.

$

Exclusive licences to incorporate patented drug delivery technologies in our products, including advanced formulations
that enhance absorption and improve dosing and shelf stability.

$

PK studies in progress to launch new drug delivery platforms: Sublingual tablets, metered dose inhalers.

$

Trusted IMC-GMP certified supplier of APIs to leading pharmaceutical companies, universities and research
partnerships and proprietary production procedures for several isolated cannabinoids.

FOCUS AREAS

;

Cannabinoid Extracts and APIs – Cannabinoid based extracts and APIs to leading pharmaceutical
companies, universities and research partnerships.

;

Discover other cannabinoids and formulations combined with innovative pharmaceutical delivery solutions by engaging in R&D [research and development].

;

Cannabinoid Based Products – Contract manufacturing of private label and  branded finished product including medical 
cannabis and health and wellness products.

;

Become a global leader in producing medical cannabis and innovative cannabis products, including new pharmaceutical drugs.

;

Medical Cannabis initially for selected European and Australian markets.

;

Develop drugs to meet unmet medical needs focused on therapeutic areas including central nervous system, pain and
palliative care management, and
inflammation and autoimmune disorders.